Guanosine Potentiates the Antiproliferative Effect of Cytosine-β-D-Arabinofuranoside in Melanoma Cell Lines

References

• Sidi Y, Hudson J L, Mitchell B S. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells. Cancer Res 1985; 45: 4940–4945
   PubMed Web of Science ®Google Scholar
• Holland J F, Glidewell M A, Ellison R R, et al. Acute myelocytic leukemia. Arch Intern Med 1976; 136: 1377–1381
   PubMed Web of Science ®Google Scholar
• Wiernik P H, Schimpff S C, Schiffer C A, et al. Randomized clinical comparison of daunorubicin alone and in combination with cytosine arabinoside, 6-thioguanine and pyrimethamine in the treatment of ANLL. Cancer Treat Rep 1976; 60: 41–53
   PubMedGoogle Scholar
• Markman M., Howell S B. The intracavitary administration of cytarabine to patients with nonhematopoeitic malignancies: An update. Semin Oncol 1987; 14: 116–120
   PubMed Web of Science ®Google Scholar
• King M E, Pfeifle C E, Howell S B. Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma. J Clin Oncol 1984; 2: 1321–1326
   PubMedGoogle Scholar
• Markman M. The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: Pharmacologic rationale and results of clinical trials. Semin Oncol 1985; 2(Suppl 3)177–183
   Google Scholar
• Ponzoni M, Lanciotti A, Melodia A, et al. Morphologic and phenotypic changes of human neuroblastoma cells in culture induced by cytosine arabinoside. Exp Cell Res 1989; 181: 226–237
   PubMed Web of Science ®Google Scholar
• Nordenberg J, Aloni D., Wasserman L, et al. Dimethylthiourea inhibition of melanoma cell growth in vitro and in vivo. J Natl Cancer Inst 1985; 75: 891–895
   PubMed Web of Science ®Google Scholar
• Nordenberg J, Wasserman L., Beery, et al. Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide. Exp Cell Res 1986; 162: 77–85
   PubMed Web of Science ®Google Scholar
• Sidi Y, Panel C, Wasserman L, et al. Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor. Br J Cancer 1987; 58: 61–63
   Web of Science ®Google Scholar
• Hamburger A W, Salmon S E. Primary bioassay of human tumor stem cells. Science 1977; 197: 461–463
   PubMed Web of Science ®Google Scholar
• Wasserman L, Nordenberg J, Beery E, et al. Differential effects of sodium butyrate and dimethylsulfoxide on T glutamyltranspep-tidase and alkaline phosphatase activities in MCF-7 breast cancer cells. Exp Cell Biol 1987; 55: 189–193
   Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, et al. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Riva C M, Rostum Y M. 1-β-D-Arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response. Cancer Res 1985; 45: 6244–6249
   PubMed Web of Science ®Google Scholar
• Labarca C, Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal Biochem 1980; 102: 344–352
   PubMed Web of Science ®Google Scholar
• Kufe D W, Major P P, Egan E R, et al. Correlation of cytotoxicity with incorporation of ara-C into DNA. J Biol Chem 1980; 255: 8997–9000
   PubMed Web of Science ®Google Scholar
• Ross D D, Thompson B W, Joneckis C C, et al. Metabolism of ara-C by blast cells from patients with ANLL. Blood 1986; 76: 76–82
   Google Scholar
• Arner E S, Flygor M, Bobman C, et al. Deoxycytidine kinase is constitutively expressed in human lymphocytes: Consequences for compartmentalization effects, unscheduled DNA synthesis and viral replication in resting cells. Exp. Cell Res 1988; 178: 335–342
   Web of Science ®Google Scholar
• Hordern J, Henderson J F. Comparison of purine and pyrimidine metabolism in G, and S phases of HeLa and Chinese hamster ovary cells. Can J Biochem 1982; 60: 422–433
   PubMedGoogle Scholar
• Wan C W, Mak T W. Deoxycytidine kinase and cytosine nucleoside deaminase activities in synchronized cultures of normal rat kidney cells. Cancer Res 1987; 38: 2768–2772
   Google Scholar
• Coleman C N, Stoller R G, Drake J C, et al. Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes. Blood 1975; 68: 791–803
   Google Scholar
• Iigo M, Kuretani K, Hoshi A. Relationship between anti-tumor effect and metabolites of 5-flurouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system. Cancer Res 1983; 43: 5687–5694
   PubMed Web of Science ®Google Scholar
• Iigo M, Nakashima Y, Kuretani K, et al. Potentiation of the che-motherapeutic effect 5-fluorouracil by combination with guanosine monophosphate. Gann 1983; 74: 291–298
   PubMedGoogle Scholar
• Grant S, Lehman C, Cadman E. Enhancement of l-β-D-arabin furanosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure. Cancer Res 1980; 40: 1525–1531
   PubMedGoogle Scholar
• Rauscher F, III, Cadman E D. Biochemical and cytokinetic modulation of LI210 and HL-60 cells by hydroxyurea and effect on 1-β-D-arabinofuranosylcytosine metabolisn and cytotoxicity. Cancer Res 1983; 43: 2688–2693
   PubMed Web of Science ®Google Scholar
• Ross D D, Akman S A, Joneckis C C, et al. Schedule-dependent enhancement of 1-β-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine. Cancer Res 1984; 44: 1530–1535
   PubMed Web of Science ®Google Scholar
• Yang J L, Chang E H, Capizzi R L, et al. Effect of uracil arabino-side on metabolism and cytotoxicity of cytosine arabinoside in L5178 murine leukemia. J Clin Invest 1985; 75: 141–146
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kim S H, Tahara M, et al. Potentiation of cytotoxicity of 1-β-D-arabino-furanosylcytosine for K562 human leukemic cells by cadeguomycin. Cancer Res 1987; 47: 713–717
   PubMed Web of Science ®Google Scholar
• Wu R T, Okabe T, Kim S H, et al. Enhancement of pyrimidine nucleoside uptake into K562 and YAC-1 cells by cadeoguomycin. J Antibiotics 1985; 38: 1588–1595
   PubMed Web of Science ®Google Scholar